Patents by Inventor Haiming Wei

Haiming Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PUMP HEAD ELEMENT AND PUMP HEAD COMPRISING SAME, AND CONTAINER
    Publication number: 20240026877
    Abstract: A pump head element and a pump head comprising same, and a container. The pump head element comprises a buffer liquid portion (11), an opening portion (12), and a closed end (13); the opening portion (12) has one end communicated with the buffer liquid portion (11) and the other end connected to the closed end (13); the internal space of the buffer liquid portion (11) and the internal space of the opening portion (12) are defined as liquid storage space (14); the liquid storage space (14) has one end closed by an externally provided piston (2) and the other end closed by the closed end (13); and the opening portion (12) comprises an opening (15) through which liquid to be extracted enters or leaves the liquid storage space (14).
    Type: Application
    Filed: June 15, 2023
    Publication date: January 25, 2024
    Applicant: BEIJING RED-SEA TECH CO., LTD.
    Inventors: Zengxin CHEN, Shenglu LI, Jiansong XIA, Chen LI, JINxia WEI, Changchun ZHOU, Haiming WEI, Jingzhe CHEN, Bin CHEN
  • Antibody or antibody fragment capable of binding to lung-specific X protein and use thereof
    Patent number: 10919978
    Abstract: The present application provides an antibody or antibody fragment capable of binding to a lung-specific X protein and being used to treat a tumor, and a use thereof. The antibody or antibody fragment includes heavy chain CDRs having amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 and light chain CDRs having amino acid sequences of SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6. Alternatively, the antibody or antibody fragment includes heavy chain CDRs having amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 7, and SEQ ID NO: 3 and light chain CDRs having amino acid sequences of SEQ ID NO: 8, SEQ ID NO: 5, and SEQ ID NO: 6. The antibody is a chimeric antibody.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: February 16, 2021
    Assignee: IMMUNOPHARMACEUTIC INSTITUTE OF HEFEI RUIDA CO., LTD.
    Inventors: Zhigang Tian, Haiming Wei, Xiaohu Zheng, Rui Sun, Weihua Xiao, Dan Liu, Baoru Wang
  • ANTIBODY OR ANTIBODY FRAGMENT CAPABLE OF BINDING TO LUNG-SPECIFIC X PROTEIN AND USE THEREOF
    Publication number: 20190322758
    Abstract: The present application provides an antibody or antibody fragment capable of binding to a lung-specific X protein and being used to treat a tumor, and a use thereof. The antibody or antibody fragment includes heavy chain CDRs having amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 and light chain CDRs having amino acid sequences of SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6. Alternatively, the antibody or antibody fragment includes heavy chain CDRs having amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 7, and SEQ ID NO: 3 and light chain CDRs having amino acid sequences of SEQ ID NO: 8, SEQ ID NO: 5, and SEQ ID NO: 6. The antibody is a chimeric antibody.
    Type: Application
    Filed: May 25, 2017
    Publication date: October 24, 2019
    Applicant: Immunopharmaceutic Institute of Hefei Ruida Co., Ltd.
    Inventors: Zhigang Tian, Haiming Wei, Xiaohu Zheng, Rui Sun, Weihua Xiao, Dan Liu, Baoru Wang